CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities
Net loss	$ (6,498,222)	$ (5,698,760)
Adjustments to reconcile net loss to cash provided by operating activities
Stock based compensation expense	319,809	314,065
Depreciation and amortization	3,348,008	3,517,903
Gain on sale of assets	(12,344)	(31,443)
Contingent consideration reduction	0	15,564
Bad debt and reduction in allowance for bad debt	65,443	(360,926)
(Decrease) increase in fair value of derivative warrant liability	(1,587,782)	959,077
(Gain) loss on commodity derivative contracts	(4,484,798)	1,069,778
Net cash settlements on commodity derivatives	4,781,183	(967,708)
Amortization of debt discount and deferred costs	47,826	286,954
Changes in operating assets and liabilities
Accounts receivable	4,986,003	(2,111,591)
Inventory	3,711,239	2,338,814
Prepaid expenses	1,834,361	1,948,771
Accounts payable	(269,740)	(518,050)
Accrued expenses	(2,150,272)	(187,349)
Other assets	(378,547)	0
Net cash provided by operating activities	3,712,167	543,971
Cash flows from investing activities
Acquisition	1,822,690	0
Internally developed software	(49,229)	0
Purchase of fixed assets	(1,526,379)	(2,419,599)
Proceeds from sale of fixed assets	22,844	86,846
Net cash used in investing activities	(3,375,454)	(2,332,753)
Cash flows from financing activities
Payments on finance leases	(162,312)	(61,638)
Proceeds from exercise of stock options	0	4,500
Distribution VRM LA	0	285,534
Contributions received from redeemable noncontrolling interest	21,000,000	0
Line of credit (payments) proceeds, net	(3,276,230)	1,235,251
Proceeds from note payable (includes proceeds from PPP note)	4,374,643	187,501
Payments on note payable	(8,618,202)	(1,542,903)
Net cash provided by (used in) financing activities	13,317,899	(462,823)
Net change in cash, cash equivalents and restricted cash	13,654,612	(2,251,605)
Cash, cash equivalents, and restricted cash at beginning of the period	4,199,825	2,849,831
Cash, cash equivalents, and restricted cash at end of period	17,854,437	598,226
SUPPLEMENTAL INFORMATION
Cash paid for interest	562,259	1,221,363
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B1 Preferred Stock	1,471,238	1,093,600
Dividends-in-kind accrued on Series B and B1 Preferred Stock	704,716	819,670
Equipment acquired under finance leases	888,764	621,000
Initial adjustment of carrying amount redeemable noncontrolling interest	9,091,068	0
Accretion of redeemable noncontrolling interest to redemption value	12,348,238	0
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B1 Preferred Stock into common stock	3,368,474	$ 150,010
Dividends-in-kind accrued on Series B and B1 Preferred Stock	$ 171,380